X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adolescent (5) 5
adult (5) 5
double-blind method (5) 5
female (5) 5
humans (5) 5
index medicus (5) 5
vaccines (5) 5
analysis (4) 4
cervical intraepithelial neoplasia - prevention & control (4) 4
cervical intraepithelial neoplasia - virology (4) 4
papillomavirus infections (4) 4
papillomavirus infections - prevention & control (4) 4
young-women (4) 4
adjuvants, immunologic - administration & dosage (3) 3
cancer (3) 3
cervical cancer (3) 3
clinical trials (3) 3
hematology, oncology and palliative medicine (3) 3
human papillomavirus (3) 3
human papillomavirus 16 - immunology (3) 3
human papillomavirus 18 - immunology (3) 3
human-papillomavirus infection (3) 3
oncology (3) 3
papillomavirus vaccines - administration & dosage (3) 3
particle vaccine (3) 3
prevention (3) 3
research (3) 3
time factors (3) 3
treatment outcome (3) 3
uterine cervical neoplasms - pathology (3) 3
uterine cervical neoplasms - virology (3) 3
womens health (3) 3
young adult (3) 3
adults (2) 2
age factors (2) 2
aluminum hydroxide - administration & dosage (2) 2
asia (2) 2
australia (2) 2
cervical intraepithelial neoplasia - diagnosis (2) 2
cervical intraepithelial neoplasia - pathology (2) 2
cervix (2) 2
cross infection (2) 2
dna (2) 2
dna, viral - analysis (2) 2
double-blind (2) 2
epitopes (2) 2
europe (2) 2
follow-up (2) 2
health aspects (2) 2
human medicine (2) 2
human papillomavirus 16 - genetics (2) 2
human papillomavirus 18 - genetics (2) 2
infections (2) 2
intraepithelial neoplasia (2) 2
lipid a - administration & dosage (2) 2
lipid a - analogs & derivatives (2) 2
major capsid protein (2) 2
medical colleges (2) 2
neoplasm grading (2) 2
north america (2) 2
nosocomial infections (2) 2
oncology, experimental (2) 2
papillomavirus infections - diagnosis (2) 2
papillomavirus infections - virology (2) 2
papillomaviruses (2) 2
persistence (2) 2
sexually transmitted diseases (2) 2
south america (2) 2
uterine cervical neoplasms - diagnosis (2) 2
uterine cervical neoplasms - prevention & control (2) 2
vaccination (2) 2
young adults (2) 2
3111 biomedicine (1) 1
abridged index medicus (1) 1
adenocarcinoma (1) 1
adenocarcinoma - diagnosis (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - prevention & control (1) 1
adenocarcinoma - virology (1) 1
adolescence (1) 1
adolescent women (1) 1
age (1) 1
aged 16-26 years (1) 1
algorithms (1) 1
alphapapillomavirus (1) 1
antigens, viral - immunology (1) 1
autoimmune diseases (1) 1
biopsy (1) 1
broad-spectrum (1) 1
carcinogenesis (1) 1
carcinogènesi (1) 1
carcinoma (1) 1
care and treatment (1) 1
cells (1) 1
cervical intraepithelial neoplasia - etiology (1) 1
cervix dysplasia (1) 1
cervix uteri - metabolism (1) 1
cervix uteri - pathology (1) 1
cervix uteri - virology (1) 1
children (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e79260
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.